Back to team overview
Dr. Paul Stahl
German and European Patent Attorney Trainee
M.Sc. Biochemistry
Paul Stahl is a patent attorney trainee at Maiwald. His work mainly concerns protection of IP rights relating to biochemistry, biotechnology and pharmacy. He has special expertise in the fields of antibody and cancer research, bioconjugation, and high-throughput screening
While working on his doctorate at the Center for Medical Biotechnology in Essen, he developed cell-penetrating inhibitory nanobody conjugates and investigated their effects on cancer-relevant proteins. As a research scientist at Bayer Pharmaceuticals, he developed new methods for constructing focused, highly complex phage libraries.
He has presented his research at international conferences and published in peer-reviewed journals.
- Patent grant procedures and portfolio management
- Planning filing strategies and drafting patent applications
- Preparing freedom to operate and validity opinions
- Opposition and nullity proceedings
- Scholarship (research grant) from the Center for Medical Biotechnology (ZMB) in the new special research area SFB1093
-
Falke K, Schröder E, Mosel S, et al. (2024), Old Passengers as New Drivers: Chromosomal Passenger Proteins Engage in Translesion Synthesis. Cells.
- Balszuweit et al. (2024), Merging Cyanostilbenes with Guanidiniocarbonylpyrroles – Photoswitchability, cellular uptake and photophysical characterization. Chem. Eur. J., 4/2023
-
Stahl et al. (2023), Tuning nanobodies’ bioactivity: Coupling to ultrasmall gold nanoparticles allows the intracellular interference with Survivin. Small.
-
Oelschlaeger et al. (2023), Taspase1 Facilitates Topoisomerase IIβ-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription. Cells.
- Dirksmeyer and Stahl et al. (2022), Advances towards Cell Specific Gene Transfection – A Small Molecule Approach Allows for Order of Magnitude Selectivity. Chem. Eur. J.
- Hensel and Stahl et al. (2022), The Taspase1/Myosin1f-axis regulates filopodia dynamics
-
Maity et al. (2020), Cancer Cell Specific Drug Delivery by a Tumor-Homing CPP-Gossypol Conjugate Employing a Tracelessly Cleavable Linker. Chem. Eur. J.
- German
- English
